| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 1578 |
| 1 | OMEPRAZOLE | 1452 |
| 2 | FUROSEMIDE | 778 |
| 3 | PANTOPRAZOLE | 754 |
| 4 | METFORMIN | 599 |
| 5 | METFORMIN ER 500 MG | 534 |
| 6 | METFORMIN ER 750 MG | 534 |
| 7 | ASPIRIN | 528 |
| 8 | ASPIRIN 325 MG | 511 |
| 9 | ASPIRIN 81 MG | 511 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANITUMUMAB | 478 | 0.0495 |
| 1 | NECITUMUMAB | 8 | 0.0452 |
| 2 | POLATUZUMAB VEDOTIN | 19 | 0.0237 |
| 3 | MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE | 6 | 0.0232 |
| 4 | CAMPHOR AND MENTHOL | 3 | 0.0229 |
| 5 | CETUXIMAB | 508 | 0.0215 |
| 6 | DEXRAZOXANE | 13 | 0.0195 |
| 7 | DIGITALIS | 5 | 0.0192 |
| 8 | FOSCARNET SODIUM | 40 | 0.0175 |
| 9 | MAGNESIUM SULFATE HEPTAHYDRATE | 123 | 0.0164 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 2052 |
| 1 | Platinum-based Drug [EPC] | 1109 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1005 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 979 |
| 4 | Corticosteroid [EPC] | 878 |
| 5 | Loop Diuretic [EPC] | 836 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 793 |
| 7 | Benzodiazepine [EPC] | 652 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 558 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 531 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Metal Chelator [EPC] | 1 | 0.0435 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 979 | 0.0295 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0080 |
| 3 | CD22-directed Immunoconjugate [EPC] | 9 | 0.0080 |
| 4 | Platinum-based Drug [EPC] | 1109 | 0.0079 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 6 | 0.0072 |
| 6 | Thiazide-like Diuretic [EPC] | 177 | 0.0068 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 76 | 0.0064 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 60 | 0.0061 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 30 | 0.0054 |